Porter K - Search Results

1

Putnak R, Porter K, Schmaljohn C. Putnak R, et al. Among authors: porter k. Adv Virus Res. 2003;61:445-68. doi: 10.1016/s0065-3527(03)61012-2. Adv Virus Res. 2003. PMID: 14714440 Review. No abstract available.

2

Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques.

Simmons M, Porter KR, Hayes CG, Vaughn DW, Putnak R. Simmons M, et al. J Virol. 2006 Oct;80(19):9577-85. doi: 10.1128/JVI.00284-06. J Virol. 2006. PMID: 16973561 Free PMC article.

3

Development of dengue DNA vaccines.

Danko JR, Beckett CG, Porter KR. Danko JR, et al. Vaccine. 2011 Sep 23;29(42):7261-6. doi: 10.1016/j.vaccine.2011.07.019. Epub 2011 Jul 21. Vaccine. 2011. PMID: 21777640 Review.

4

Needle-free injection of DNA vaccines: a brief overview and methodology.

Raviprakash K, Porter KR. Raviprakash K, et al. Among authors: porter kr. Methods Mol Med. 2006;127:83-9. doi: 10.1385/1-59745-168-1:83. Methods Mol Med. 2006. PMID: 16988448 Review.

5

A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.

Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K. Raviprakash K, et al. Among authors: porter k. Virology. 2006 Sep 15;353(1):166-73. doi: 10.1016/j.virol.2006.05.005. Epub 2006 Jun 30. Virology. 2006. PMID: 16814355 Free article.

6

Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses.

Porter KR, Kochel TJ, Wu SJ, Raviprakash K, Phillips I, Hayes CG. Porter KR, et al. Arch Virol. 1998;143(5):997-1003. doi: 10.1007/s007050050348. Arch Virol. 1998. PMID: 9645204

7

A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques.

Chen L, Ewing D, Subramanian H, Block K, Rayner J, Alterson KD, Sedegah M, Hayes C, Porter K, Raviprakash K. Chen L, et al. Among authors: porter k. J Virol. 2007 Nov;81(21):11634-9. doi: 10.1128/JVI.00996-07. Epub 2007 Aug 22. J Virol. 2007. PMID: 17715224 Free PMC article.

8

Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial.

Beckett CG, Tjaden J, Burgess T, Danko JR, Tamminga C, Simmons M, Wu SJ, Sun P, Kochel T, Raviprakash K, Hayes CG, Porter KR. Beckett CG, et al. Among authors: porter kr. Vaccine. 2011 Jan 29;29(5):960-8. doi: 10.1016/j.vaccine.2010.11.050. Epub 2010 Nov 25. Vaccine. 2011. PMID: 21111785 Clinical Trial.

9

Tetravalent DNA vaccine product as a vaccine candidate against dengue.

Porter KR, Teneza-Mora N, Raviprakash K. Porter KR, et al. Methods Mol Biol. 2014;1143:283-95. doi: 10.1007/978-1-4939-0410-5_17. Methods Mol Biol. 2014. PMID: 24715294

10

Nucleic acid (DNA) immunization as a platform for dengue vaccine development.

Porter KR, Raviprakash K. Porter KR, et al. Vaccine. 2015 Dec 10;33(50):7135-40. doi: 10.1016/j.vaccine.2015.09.102. Epub 2015 Oct 14. Vaccine. 2015. PMID: 26458805 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,981 results

Search Page

Filters